<p>Bio-Rad 實驗室（NYSE:BIO.B - 獲取免費報告）於週四公佈了季度財報。根據 Zacks 的報告，該公司本季度每股收益為 1.89 美元。Bio-Rad 實驗室的淨利潤率為 29.42%，股本回報率為 3.86%。</p>
<p>獲取 <strong>Bio-Rad 實驗室</strong> 的提醒：</p>
<h2>Bio-Rad 實驗室股票表現</h2>
<p>週四，BIO.B 股票在交易時段上漲了 22.45 美元，達到 299.45 美元。該公司的交易量為 3 股，而其平均交易量為 273 股。該公司的 50 日移動平均價格為 275.80 美元，200 日移動平均價格為 295.25 美元。公司的債務與股本比率為 0.16，速動比率為 4.19，流動比率為 5.62。該公司的市值為 80.8 億美元，市盈率為 10.73，貝塔值為 0.98。Bio-Rad 實驗室的年內最低價為 247.05 美元，年內最高價為 321.12 美元。</p>
<h2>Bio-Rad 實驗室公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Bio-Rad 實驗室公司是一家全球領先的創新產品和系統提供商，服務於生命科學研究和臨牀診斷市場。該公司通過兩個主要部門運營：生命科學部門，提供用於研究應用的儀器、耗材和軟件；臨牀診斷部門，提供血型、免疫學和分子檢測的質量控制材料和試劑系統。Bio-Rad 的產品組合支持廣泛的應用，包括蛋白質分析、基因表達、細胞生物學和數字 PCR。</p>
<p>在生命科學部門，Bio-Rad 開發和營銷電泳和成像系統、色譜儀器、實驗室耗材和簡化實驗工作流程的軟件平台等技術。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們認為比 Bio-Rad 實驗室更好的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUJJTy5C?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUJJTy5C"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Bio-Rad 實驗室嗎？</h2>
<p>在考慮 Bio-Rad 實驗室之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛的市場注意到之前立即購買的股票……而 Bio-Rad 實驗室並不在名單上。</p>
<p>雖然 Bio-Rad 實驗室目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

Bio-Rad實驗室-B

<p>Bio-Rad 實驗室（NYSE:BIO.B）報告季度每股收益為 1.89 美元，淨利潤率為 29.42%，股本回報率為 3.86%。該股票上漲 22.45 美元，至 299.45 美元，市值為 80.8 億美元。該公司在生命科學和臨牀診斷領域運營，提供創新的產品和系統。分析師目前對該股票的評級為持有，但建議其他股票可能是更好的投資選擇</p>

<p>Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) announced its quarterly earnings results on Thursday. The company reported $1.89 EPS for the quarter, Zacks reports. Bio-Rad Laboratories had a net margin of 29.42% and a return on equity of 3.86%.</p>
<div class="lb-trans"><p>Bio-Rad 實驗室（NYSE:BIO.B - 獲取免費報告）於週四公佈了季度財報。根據 Zacks 的報告，該公司本季度每股收益為 1.89 美元。Bio-Rad 實驗室的淨利潤率為 29.42%，股本回報率為 3.86%。</p>
</div><p>Get <strong>Bio-Rad Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Bio-Rad 實驗室</strong> 的提醒：</p>
</div><h2>Bio-Rad Laboratories Stock Performance</h2>
<div class="lb-trans"><h2>Bio-Rad 實驗室股票表現</h2>
</div><p>Shares of BIO.B stock traded up $22.45 during trading hours on Thursday, reaching $299.45. The company had a trading volume of 3 shares, compared to its average volume of 273. The business has a fifty day moving average price of $275.80 and a 200-day moving average price of $295.25. The company has a debt-to-equity ratio of 0.16, a quick ratio of 4.19 and a current ratio of 5.62. The firm has a market cap of $8.08 billion, a PE ratio of 10.73 and a beta of 0.98. Bio-Rad Laboratories has a one year low of $247.05 and a one year high of $321.12.</p>
<div class="lb-trans"><p>週四，BIO.B 股票在交易時段上漲了 22.45 美元，達到 299.45 美元。該公司的交易量為 3 股，而其平均交易量為 273 股。該公司的 50 日移動平均價格為 275.80 美元，200 日移動平均價格為 295.25 美元。公司的債務與股本比率為 0.16，速動比率為 4.19，流動比率為 5.62。該公司的市值為 80.8 億美元，市盈率為 10.73，貝塔值為 0.98。Bio-Rad 實驗室的年內最低價為 247.05 美元，年內最高價為 321.12 美元。</p>
</div><h2>Bio-Rad Laboratories Company Profile</h2>
<div class="lb-trans"><h2>Bio-Rad 實驗室公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad's product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.</p>
<div class="lb-trans"><p>Bio-Rad 實驗室公司是一家全球領先的創新產品和系統提供商，服務於生命科學研究和臨牀診斷市場。該公司通過兩個主要部門運營：生命科學部門，提供用於研究應用的儀器、耗材和軟件；臨牀診斷部門，提供血型、免疫學和分子檢測的質量控制材料和試劑系統。Bio-Rad 的產品組合支持廣泛的應用，包括蛋白質分析、基因表達、細胞生物學和數字 PCR。</p>
</div><p>In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.</p>
<div class="lb-trans"><p>在生命科學部門，Bio-Rad 開發和營銷電泳和成像系統、色譜儀器、實驗室耗材和簡化實驗工作流程的軟件平台等技術。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Bio-Rad Laboratories</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 Bio-Rad 實驗室更好的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUJJTy5C" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NYSE&amp;Symbol=BIO.B"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Bio-Rad Laboratories Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Bio-Rad 實驗室嗎？</h2>
</div><p>Before you consider Bio-Rad Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Bio-Rad 實驗室之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛的市場注意到之前立即購買的股票……而 Bio-Rad 實驗室並不在名單上。</p>
</div><p>While Bio-Rad Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Bio-Rad 實驗室目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Bio-Rad Lab-B（NYSE:BIO.B）公佈財報結果